Mammography Market : Global Industry Analysis and Opportunity Assessment, 2035

Mammography Market Size and Share Forecast Outlook 2025 to 2035

The global Mammography Market is estimated to be valued at USD 2.2 billion in 2025 and is projected to reach USD 5.5 billion by 2035, registering a compound annual growth rate of 9.6% over the forecast period.

‍Quick Stats for Mammography Market

• Industry Value (2025): USD 2.2 billion
• Forecast Value (2035): USD 5.5 billion
• Forecast CAGR: 9.6%
• Leading Segment in 2025: Full Field Digital Mammography Equipment- 
• Key Growth Region: Asia-Pacific (China, India, South Korea, Japan)
• Top Key Players: Fujifilm Holdings Corp, Hologic Inc, GE Healthcare, Siemens Healthineers AG, Koninklijke Philips NV, Canon Medical Systems Corp, Planmed Oy.

Metric	Value
Market Size (2025E)	USD 2.2 billion
Market Value (2035F)	USD 5.5 billion
CAGR (2025 to 2035)	9.6%

The global mammography market is experiencing significant growth, propelled by the increasing prevalence of breast cancer and heightened awareness of early detection's importance. Advancements in imaging technologies, such as digital mammography, 3D breast tomosynthesis, and contrast-enhanced mammography, have enhanced diagnostic accuracy and patient outcomes.

Government initiatives and public health campaigns are further encouraging regular screenings, contributing to market expansion. Additionally, the integration of artificial intelligence (AI) in mammography is streamlining workflows and improving diagnostic precision, making screenings more accessible and efficient.

The market's growth is also supported by the development of mobile mammography units, which extend services to underserved areas, and favorable reimbursement policies that reduce financial barriers for patients. Overall, the mammography market is poised for continued growth, driven by technological innovations, supportive policies, and a global emphasis on early breast cancer detection.

Analyzing Mammography Market by Top Investment Segments

Full Field Digital Mammography Equipment Lead the Market Due to Increasing Preference for High-Resolution Imaging and Workflow Efficiency

The dominance of full field digital mammography equipment, accounting for 46.8% of the mammography market revenue in 2025, has been attributed to the significant shift from analog to digital infrastructure across healthcare facilities. Greater diagnostic accuracy, improved image clarity, and reduced examination time have been prioritized by radiologists and healthcare providers, driving the adoption of digital platforms.

Furthermore, integration capabilities with Picture Archiving and Communication Systems (PACS) have enabled seamless data management, contributing to clinical workflow optimization. Supportive reimbursement frameworks in developed markets and reduced total cost of ownership over time have strengthened hospital budgets in favor of digital equipment. The increased focus on early detection and preventive screening programs by public health agencies has further reinforced investment in digital systems.

Digital Mammography Leads the Market Due to Government-Led Screening Programs

Digital mammography, commanding an 80.9% revenue share in 2025, has been preferred for its enhanced sensitivity and diagnostic yield compared to analog and film-based technologies. Market penetration has been accelerated through national breast screening programs that mandate the use of digital equipment for consistent and scalable diagnostics.

Real-time image visualization, lower radiation exposure, and superior data storage capacity have made digital mammography the modality of choice for high-volume screening centers. Strategic funding by governmental and private healthcare institutions has ensured rapid technology replacement cycles in favor of digital platforms. Furthermore, collaborations between OEMs and public health bodies have facilitated the deployment of mobile digital mammography units, expanding access in rural populations.

Hospitals Dominate the Market Due to Advanced Infrastructure and Patient Trust in In-House Diagnostic Services

Hospitals are estimated to contribute 45.68% to the global mammography market revenue in 2025, largely due to their integrated diagnostic and treatment capabilities. The presence of advanced infrastructure, multidisciplinary care teams, and round-the-clock access to imaging specialists has made hospitals the preferred destination for breast cancer screening and diagnostics.

Mammography procedures in hospitals are often bundled with additional services such as biopsies, pathology reviews, and oncology consultations, allowing for a comprehensive care pathway. Investments in state-of-the-art imaging suites have been supported through capital funding initiatives and public-private partnerships, further strengthening the diagnostic armamentarium of tertiary hospitals.

Challenges and Opportunities

Challenge

High Equipment and Maintenance Costs

Mammography is an expensive business because the starting costs of purchasing and maintaining equipment are exorbitant. Initial costs for both digital and 3D mammography systems deter small-scale diagnostic centres from making these available. Most small diagnostic centres operate in low- and middle-income economies.

This equipment requires trained personnel who have the capability of interpreting images correctly and operating the system efficiently, thereby making operations costlier to manage. The main result of all these factors is limited adoption of mammography systems in countries with low economic viability.

Opportunity

Technological Advancements and AI Integration

Integration of cutting-edge imaging technologies into artificial intelligence, for instance, is expected to create tremendous space for the mammography systems market. It enables diagnostic accuracy and correction of false positives and false negatives while supporting radiologists across the areas of early cancer assessment by connecting portable and mobile mammography units to far-off regions and rural populations, enhancing the screening services that travel much farther afield. Thus, innovations are destined to realize improvements in detection efficiency globally and stimulate growth in the overall market.

Country-wise Insights

United States

With the growing campaign for early detection of breast cancer among the population and rigorous government programs such as the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), the mammography market in the United States witnesses rapid growth. The country benefits from widespread screening programs and fast adoption master-level advanced imaging technologies with comprehensive reimbursement regimes.

Country	CAGR (2025 to 2035)
United States	9.9%

United Kingdom

The growth of the mammography market in the UK is being driven by government-endorsed screening programs and greater awareness towards breast health. The National Health Service (NHS) provides an organized breast screening service that enhances early diagnostic efforts and continuity of monitoring.

Improvements in imaging systems coupled with training for radiologists have helped grow the diagnostic power in the country considerably. Increasing breast cancer cases, public awareness, and advanced innovations in 3D imaging continue to spur phenomenal market growth.

Country	CAGR (2025 to 2035)
United Kingdom	9.2%

European Union

Mammography in the European Union is spawning consistent growth due to synergistic policies on cancer screening and the usage of digital imaging technologies. Germany, France, and Italy lead in deploying high-resolution 2D and 3D mammography units.

The European Commission is promoting breast cancer screening, and regulatory incentives further facilitate the modernization of equipment. Inter-country collaborative clinical research and AI integration are being promoted for enhancing diagnostic accuracy and encouraging early intervention strategies.

Country	CAGR (2025 to 2035)
European Union	9.5%

Japan

Mammography in Japan is getting better almost to the end-of-the-era government emphasis on early discovery and public awareness about the diseases. The Ministry of Health, Labour, and Welfare is often seen conducting screening campaigns and supporting mobile mammography services, especially in the countryside.

An increase in the elderly population and incidence of breast cancer in the country has created a higher demand for advanced diagnostic systems. Small, compact devices are getting domestic manufacturers and global leaders pushing development. These devices are AI-embedded models aimed at both urban clinics and regional hospitals.

Country	CAGR (2025 to 2035)
Japan	8.7%

South Korea

The mammography market in South Korea is growing very rapidly due to the increased awareness of breast cancers and the improvement of the health systems in the country. Health insurance has made regular screenings easy as they are now covered under national health insurance schemes.

Health promotion policies are for early detection from the government. Emerging Next-Gen mammography technologies are being adopted using some very strong digital health capabilities and a highly advanced medical device manufacturing ecosystem. The rising appeal of low-radiation diagnostics is rapidly increasing market momentum.

Country	CAGR (2025 to 2035)
South Korea	9.5%

Competition Outlook

The mammography market is witnessing intense competition, driven by continuous innovation, rapid product launches, and strategic collaborations among imaging technology providers. Significant focus is being placed on the development of AI-integrated diagnostic platforms, portable mammography units, and 3D tomosynthesis systems to enhance detection accuracy and expand accessibility.

Companies are actively investing in R&D and expanding manufacturing capabilities to cater to the growing demand for advanced breast screening solutions. Additionally, partnerships with hospitals, diagnostic chains, and public health agencies are being leveraged to deploy digital solutions at scale, especially in underserved regions.

Competitive pricing strategies, along with after-sales service enhancements, are further shaping vendor differentiation. Regulatory approvals and global certification standards are also being prioritized to accelerate international market penetration.

Key Development

• In 2024, GE HealthCare unveiled Pristina Via, a new mammography system designed to enhance screening for technologists and patients. It offers zero-click acquisition, faster image cycles, and lower radiation doses, aiming to streamline workflows amidst technologist shortages and provide more personalized care.
• In 2024, Fujifilm showcased Amulet Sophinity, a new mammography technology, at ECR 2024. This digital system aims for improved accuracy, workflow with AI, and patient comfort. It offers low-dose, high-quality images with 50 µm pixel size and dual-angle tomosynthesis for enhanced breast cancer diagnosis.

Companies

• Fujifilm Holdings Corp
• Hologic Inc
• GE Healthcare
• Siemens Healthineers AG
• Koninklijke Philips NV
• Canon Medical Systems Corp
• Planmed Oy
• Panacea Medical Technologies Pvt Ltd.
• Hitachi Ltd.
• USA Electronics, Inc.

Key Segmentation

By Product Type:

• Breast Tomosynthesis
• Film Screen Systems
• X-Ray
• Others

By Technology Type:

• Digital
• Analog
• 3-D
• 2-D

By End Use:

• Hospitals
• Special Clinics
• Diagnosis Centers
• Ambulatory Surgical Centers
• Educational & Research Institutes

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific
• Japan
• The Middle East & Africa